# CASE WESTERN RESERVE UNIVERSITY: Quantifying and Personalizing the Clinical Benefit of Metastasis-Directed Therapy in Men with De Novo Oligometastatic Prostate Cancer

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | CASE WESTERN RESERVE UNIVERSITY |
| Location | CLEVELAND, OH |
| Project | Quantifying and Personalizing the Clinical Benefit of Metastasis-Directed Therapy in Men with De Novo Oligometastatic Prostate Cancer |
| Project number | 5U01CA257638-04 |
| Mechanism | U01 |
| Institute | National Cancer Institute |
| Award | $528,809 |
| Awarded | 2026-08-27 |
| Project period | 2021-09-14 to 2028-08-31 |
| UEI | HJMKEF7EJW69 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11411288). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.